Summary:
Join a clinical research study of Crohn’s disease.
Wake Research Associates is enrolling volunteers with Crohn’s disease in a study evaluating the effectiveness of a nutritional intervention in improving bowel health when combined with usual medical care.
Qualified Participants Must:
• Be age 18-85
•
Have a confirmed history of Crohn’s Disease
On a stable dose of infliximab, adalimumab, or certolizumab 8 weeks prior to joining the study
•
Be able to consume oral nutrition (2, 4 ounce services daily) for up to 24 weeks
*Other conditions may apply
Qualified Participants May Receive:
Qualified participants may receive:
- Study-related intervention or placebo at no cost
- Study-related medical exams at no cost
- Compensation for time and travel
Insurance is not needed to participate in this study